Alltrna, a startup developing a new class of RNA-based drugs where a single therapy could potentially be reused across many different diseases, has received clearance to begin its first clinical trial, the company told Endpoints …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844